Amicus Therapeutics Inc (FOLD)

Oct 12, 2025

Why Amicus Therapeutics Inc. stock is a must watch in 2025Treasury Yields & AI Powered Trade Plan Recommendations - newser.com

Oct 12, 2025

Oct 10, 2025

What Fibonacci levels say about Amicus Therapeutics Inc. reboundPortfolio Return Report & Consistent Profit Trade Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Can volume confirm reversal in Amicus Therapeutics Inc.Market Growth Summary & Reliable Breakout Stock Forecasts - newser.com

Oct 10, 2025

Oct 10, 2025

Will a bounce in Amicus Therapeutics Inc. offer an exitMarket Movers & Risk Controlled Stock Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Heatmap analysis for Amicus Therapeutics Inc. and competitorsEarnings Recap Summary & Entry Point Confirmation Signals - newser.com

Oct 10, 2025

Oct 10, 2025

What macro factors could drive Amicus Therapeutics Inc. (AM6) stock higherJuly 2025 Summary & Accurate Technical Buy Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Developing predictive dashboards with Amicus Therapeutics Inc. dataJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Amicus Therapeutics Inc. stock prediction for this weekMarket Sentiment Report & High Accuracy Swing Trade Signals - newser.com

Oct 10, 2025

Oct 09, 2025

Is Amicus Therapeutics Inc. (AM6) stock trading at attractive multiplesPortfolio Gains Report & Risk Controlled Stock Pick Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Real time scanner hits for Amicus Therapeutics Inc. explainedJuly 2025 Selloffs & Verified Entry Point Detection - newser.com

Oct 09, 2025

Oct 08, 2025

Amicus Therapeutics (NASDAQ:FOLD) Given "Sell (E+)" Rating at Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 08, 2025

Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease - Nasdaq

Oct 08, 2025

Oct 08, 2025

Amicus Therapeutics (NASDAQ:FOLD) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat

Oct 08, 2025

Oct 08, 2025

Q3 EPS Forecast for Amicus Therapeutics Lifted by Analyst - MarketBeat

Oct 08, 2025

Oct 08, 2025

What Does Wall Street Think About Amicus Therapeutics (FOLD)? - MSN

Oct 08, 2025

Oct 07, 2025

All You Need to Know About Amicus Therapeutics (FOLD) Rating Upgrade to Strong Buy - sharewise.com

Oct 07, 2025

Oct 07, 2025

Is Amicus Therapeutics Inc AM6 a good long term investmentVWAP Trading Strategies & Consistent Triple Returns - earlytimes.in

Oct 07, 2025

Oct 07, 2025

How the Narrative Around Amicus Therapeutics Is Shifting Amid Legal and Pipeline Developments - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

Zacks.com featured highlights include Amicus Therapeutics, Micron Technology and General Dynamics - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

Amicus Therapeutics (NASDAQ:FOLD) Shares Pass Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Oct 07, 2025

Oct 06, 2025

Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Fore - PharmiWeb.com

Oct 06, 2025

Oct 06, 2025

Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Forecast to 2035 Featuring Amicus Therapeutics, Astellas, BioMarin, Maze Therapeutics, Oxyrane ParasailResearchAndMarkets.com - The AI Journal

Oct 06, 2025

Oct 06, 2025

Bet on These 3 Stocks With Upgraded Broker Ratings for Solid Returns - TradingView

Oct 06, 2025

Oct 06, 2025

What RSI levels show for Amicus Therapeutics Inc. (AM6) stockStop Loss & Weekly High Potential Stock Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

A Look at Amicus Therapeutics’s Valuation After Analyst Upgrade and Improved Outlook (FOLD) - Yahoo Finance

Oct 06, 2025

Oct 06, 2025

Is Amicus Therapeutics Inc. (AM6) stock a top pick for value investorsWeekly Volume Report & Fast Gain Swing Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Market reaction to Amicus Therapeutics Inc.’s recent newsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

How to forecast Amicus Therapeutics Inc. trends using time seriesJuly 2025 Analyst Calls & Safe Entry Point Alerts - newser.com

Oct 06, 2025

Oct 04, 2025

Needham Upgrades Amicus Therapeutics(FOLD.US) to Buy Rating, Announces Target Price $14 - 富途牛牛

Oct 04, 2025

Oct 03, 2025

Technical signs of recovery in Amicus Therapeutics Inc.2025 Investor Takeaways & AI Driven Price Forecasts - newser.com

Oct 03, 2025

Oct 03, 2025

Using Ichimoku Cloud for Amicus Therapeutics Inc. technicalsWeekly Profit Recap & Reliable Volume Spike Alerts - newser.com

Oct 03, 2025

Oct 02, 2025

Can Galafold Drive Amicus' Growth Through the Rest of 2025? - sharewise.com

Oct 02, 2025

Oct 01, 2025

Amicus Therapeutics (NASDAQ:FOLD) Trading Up 6.5%What's Next? - MarketBeat

Oct 01, 2025

Oct 01, 2025

Top chart patterns to watch in Amicus Therapeutics Inc.2025 Big Picture & Free High Return Stock Watch Alerts - newser.com

Oct 01, 2025

Oct 01, 2025

Pompe Disease Market Analysis Report 2025-2035: Enzyme Replacement Therapies and Approvals of Myozyme and Nexviazyme Drive Steady Growth - GlobeNewswire Inc.

Oct 01, 2025

Sep 29, 2025

Can Amicus Therapeutics Inc. rally from current levelsBond Market & Long Hold Capital Preservation Tips - newser.com

Sep 29, 2025